Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours. uri icon

autores

  • ANA DA CONCEIÇÃO SARAIVA E SOUSA
  • Cotton S
  • Azevedo R
  • Gaiteiro C
  • Ferreira D
  • Lima L
  • Peixoto A
  • Fernandes E
  • Pinto, M.A.

data de publicação

  • março 1, 2017